Order Article Reprints

Moldovianu A-M, Stoia R, Vasilica M, Ursuleac I, Badelita SN, Tomescu AA, Preda OD, Bardas A, Cirstea M, Coriu D. Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study. Medicina. 2023; 59(2):324. https://doi.org/10.3390/medicina59020324

Moldovianu, Ana-Maria, Razvan Stoia, Mariana Vasilica, Iulia Ursuleac, Sorina Nicoleta Badelita, Andra Alina Tomescu, Oana Diana Preda, Alexandru Bardas, Mihaela Cirstea, and Daniel Coriu. 2023. "Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study" Medicina 59, no. 2: 324. https://doi.org/10.3390/medicina59020324

Moldovianu, A.-M., Stoia, R., Vasilica, M., Ursuleac, I., Badelita, S. N., Tomescu, A. A., Preda, O. D., Bardas, A., Cirstea, M., & Coriu, D. (2023). Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study. Medicina, 59(2), 324. https://doi.org/10.3390/medicina59020324